In patients with evidence of active inflammation, reflected by elevated inflammatory markers such as ESR or CRP or by cardiac MRI findings (pericardial calcification or absence of active inflammation), an initial trial of anti-inflammatory therapy is recommended for several weeks, with close monitoring for clinical improvement. Here, CRP is linked to calcification.